Cargando…
Clinical Implications of Glyoxalase1 Gene Polymorphism and Elevated Levels of the Reactive Metabolite Methylglyoxal in the Susceptibility of Type 2 Diabetes Mellitus in the Patients from Asir and Tabuk Regions of Saudi Arabia
Diabetes mellitus constitutes a big challenge to the global health care system due to its socioeconomic impacts and very serious complications. The incidence and the prevalence rate are increased in the Gulf region including the KSA. Type 2 diabetes mellitus (T2DM) is caused by diverse risk factors...
Autores principales: | Alhujaily, Muhanad, Mir, Mohammad Muzaffar, Mir, Rashid, Alghamdi, Mushabab Ayed Abdullah, Wani, Javed Iqbal, Sabah, Zia ul, Elfaki, Imadeldin, Alnour, Tarig Mohammad Saad, Jeelani, Mohammed, Abomughaid, Mosleh Mohammad, Alharbi, Samir Abdulkarim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030104/ https://www.ncbi.nlm.nih.gov/pubmed/35455754 http://dx.doi.org/10.3390/jpm12040639 |
Ejemplares similares
-
Potential impact of GCK, MIR-196A-2 and MIR-423 gene abnormalities on the development and progression of type 2 diabetes mellitus in Asir and Tabuk regions of Saudi Arabia
por: Mir, Mohammad Muzaffar, et al.
Publicado: (2022) -
Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study
por: Mir, Mohammad Muzaffar, et al.
Publicado: (2022) -
Differential impact of the angiotensin-converting enzyme-2 (ACE2 rs4343 G>A) and miR-196a2 rs11614913 C>T gene alterations in COVID-19 disease severity and mortality
por: Mir, Mohammad Muzaffar, et al.
Publicado: (2022) -
The transcription factor HNF-4α: a key player in haematological disorders
por: Belali, Tareg, et al.
Publicado: (2021) -
Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome
por: Alhujaily, Muhanad, et al.
Publicado: (2021)